Abstract
Aims
To assess the validity of the 13C-glucose breath test (13C-GBT) to identify insulin resistance (IR) in non-diabetic individuals, using hyperinsulinemic–euglycemic clamps as gold standard. This validity was compared with that of other IR surrogates.
Methodology
Non-diabetic adults were studied in a cross-sectional design. In a first appointment, oral glucose tolerance tests were conducted simultaneously with 13C-GBTs. Oral 75 g glucose dissolved in 150 ml water, followed by 1.5 mg/Kg body weight U-13C-glucose dissolved in 50 ml water, was administered. Breath and blood samples were collected at baseline and at 30-min intervals. The percentages of glucose-oxidized dose at given periods were calculated. Clamps were conducted a week later. A clamp-derived M value ≤ 6.0 mg/kg*min was used as cut-off. ROC curves were constructed for 13C-GBT, fasting insulin, HOMA, and ISI-composite.
Results
Thirty-eight subjects completed the study protocol. The correlation coefficient between the 13C-GBT derived glucose-oxidized dose at 180 min and M values was 0.524 (p = 0.001). The optimal value to identify IR with the 13C-GBT was 4.23% (AUC 0.81; 95CI 0.66, 0.96; accuracy 0.82, 95CI 0.66, 0.92). The 13C-GBT sensitivity (0.88) was higher than HOMA and fasting insulin sensitivities (0.83 and 0.75 respectively), while their specificities were comparable (0.71, 0.71, and 0.79, respectively). The sensitivity of ISI-C was higher (0.92) than that of the 13C-GBT, but its specificity was poor (0.36). The accuracy of the 13C-GBT was superior to that of the other studied surrogates.
Conclusions
The 13C-GBT is a valid and accurate method to detect IR in non-diabetic adults. Therefore, it is potentially useful in clinical and community settings.
Similar content being viewed by others
References
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE (2017) IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50
Wilcox G (2005) Insulin and insulin resistance. Clin Biochem Rev 26:19–39
Petersen KF, Shulman GI (2006) Etiology of insulin resistance. Am J Med 119:10S–16S
Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of Type 2 Diabetes? Diabetes Care 30:1544–1548
Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Rifai LNN, Liu S (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women. Diabetes Care 30:1747–1752
DeFronzo RA, Tobin JD, Andrews R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
Trout KK, Homko C, Tkacs NC (2007) Methods of measuring insulin sensitivity. Biol Res Nurs 8:305–318
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22:1462–1470
Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snidders C, Bouter LM, Heine RJ (1996) Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general caucasian population: the hoorn study. Diabetologia 39:298–305
Uwaifo GI, Fallon EM, chin J, Elberg J, Parikh SJ, Yanovski JA (2002) Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 25:2081–2087
Gungor N. Saad R. Janosky J. Arslanian S (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47–55
Libman IM, Barinas-Mitchell E, Bartuccil A, Robertson R, Arslanian S (2008) Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 93:4231–4237
Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes obtained from the oral glucose tolerance test. Diabetes Care 30:89–94
Sonko BJ, Murgatroyd PR, Goldberg GR, Coward WA, Ceesay SM, Prentice AM (1993) Non-invasive techniques for assessing carbohydrate flux: II. Measurement of deposition using 13C-glucose. Acta Physiol Scand 147:99–108
Lewanczuk RZ, Paty BW, Toth EL (2004) Comparison of the [13C] glucose breath test to the hyperinsulinemic–euglycemic clamp when determining insulin resistance. Diabetes Care 27:441–447
Ziakun AM, Maevskiĭ EI, Sokolov EI, Starkova NT, Davydov AL, Grishina EV, Kudriavtseva AI, Zakharchenko VN, Peshenko VP, Shidlovskiĭ M (2004) Evaluation of glucose utilization in patients with insulin-independent diabetes mellitus by using breathing test. Biofizika 49:948–957
Dillon EL, Janghorbani M, Angel JA, Casperson SL, Grady JJ, Urban RJ, Volpi E, Sheffield-Moore M (2009) Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care 32:430–435
Singal P, Janghorbani M, Schuette SA, Chisholm R, Mather KJ (2010) Intra-individual variability of CO2 breath isotope enrichment compared to blood glucose in the oral glucose tolerance test. Diabetes Technol Ther 12:947–953
Maldonado-Hernández J, Martínez-Basila A, Matute González MG, López-Alarcón MG (2014) The [13C] glucose breath rest is a reliable method to identify insulin resistance in Mexican adults without diabetes: comparison with other insulin resistance surrogates. Diabetes Technol Ther 16:1–7
Ibarra-Pastrana E, Candia Plata MC, Álvarez G, Valencia ME (2012) Estimation of insulin resistance in Mexican adults by the [13C] glucose breath test corrected for endogenous total CO2 production. Intl J Endocrinol 2012:907818. https://doi.org/10.1155/2012/907818
Ghosh C, Mukhopadhyay P, Ghosh S, Pradhan M (2015) Insulin sensitivity index (ISI0, 120) potentially linked to carbon isotopes of breath CO2 for pre-diabetes and type 2 diabetes. Sci Rep. https://doi.org/10.1038/srep11959
Salas Fernández A, Maldonado Hernández J, Martínez Basila A, Martínez Razo G, Jasso-Saavedra F (2015) The 13C-glucose breath test is a valid non-invasive screening tool to identify metabolic syndrome in adolescents. Clin Chem Lab Med 53:133–138
Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E (2012) Defining insulin resistance from hyperinsulinemic–euglycemic clamps. Diabetes Care 35:1605–1610
Braden B, Lembcke B, Kuker W, Caspary WF (2007) 13C-breath tests: current state of the art and future directions. Dig Liver Dis 39:795–805
Acknowledgements
This study was supported with grants from: Consejo Nacional de Ciencia y Tecnología (CONACYT): 068915, and from the Instituto Mexicano del Seguro Social: FIS/IMSS/PROT 2007-3603-18.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that no competing financial interests exist.
Ethical approval
The protocol was approved by the Ethics Committee of the Instituto Mexicano del Seguro Social and with the 1964 Helsinki declaration (Approval Number: R-2007-3603-18).
Informed consent
Informed consent was obtained from all individual participants included in the study before the study protocol initiated.
Additional information
Managed by Massimo Porta.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maldonado-Hernández, J., Martínez-Basila, A., Rendón-Macías, M.E. et al. Accuracy of the 13C-glucose breath test to identify insulin resistance in non-diabetic adults. Acta Diabetol 56, 923–929 (2019). https://doi.org/10.1007/s00592-019-01318-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-019-01318-5